title: Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment.
abstract: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients.
authors.affiliation: Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: R T
authors.initials: RT
authors.lastname: Schlinkert
authors.forename: D M
authors.initials: DM
authors.lastname: Nagorney
authors.forename: J A
authors.initials: JA
authors.lastname: Van Heerden
authors.forename: M A
authors.initials: MA
authors.lastname: Adson
mesh_terms: D002759:Adenoma, Bile Duct / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015996:Survival Rate